Intellia Therapeutics Inc (NASDAQ:NTLA)
| 54.03 Delayed Data As of Jul 01 |  +2.25 / +4.35%Today’s Change | 37.08 Today|||52-Week Range 180.59 | -54.30% Year-to-Date |
Latest NTLA News | Press Releases
| Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High Jun 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 51.76 |
| Today’s open | 52.14 |
| Day’s range | 51.36 - 54.82 |
| Volume | 1,016,736 |
| Average volume (3 months) | 1,260,707 |
| Market cap | $4.1B |
Data as of 4:00pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -57.61% |
| Earnings growth (this year) | -52.43% |
| Earnings growth (next 5 years) | +8.76% |
| Revenue growth (last year) | -43.01% |
| P/E ratio | NM |
| Price/Sales | 253.61 |
| Price/Book | 3.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DNLIDenali Therapeutics ... | +1.81 | +6.15% |
| ---- | ||
| ARWRArrowhead Pharmaceut... | +0.75 | +2.13% |
| ZLABZai Lab Ltd | +3.86 | +11.13% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$1.28 |
| Annual revenue (last year) | $33.1M |
| Annual profit (last year) | -$267.9M |
| Net profit margin | -810.49% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
